Navigation Links
Richard Greco Joins Mediware Board
Date:9/4/2007

LENEXA, Kan., Sept. 4 /PRNewswire-FirstCall/ -- Mediware Information Systems (Nasdaq: MEDW) announced today the appointment of The Honorable Richard Greco, Jr. to the board of directors. The Company also announced that long-term director, Jonathan Churchill, resigned from the board following 15 years of valuable service.

Joining the board is The Honorable Richard Greco, Jr., age 38, former Assistant Secretary of the Navy. Mr. Greco brings tremendous expertise and experience in corporate finance and governance. As the Assistant Secretary of the Navy for financial management, Mr. Greco served as the chief financial officer of the department.

"Richard's high profile expertise is an exceptional addition to the Mediware board of directors," continued Auriana. "His knowledge and practical experience with corporate finance, governance and sound financial management will provide Mediware an advantage as we look to grow and expand within the sector."

Mr. Greco is president of Filangieri Capital Partners in New York City, a private equity partnership seeking long-term capital appreciation by investing in high growth private enterprises in Italy and emerging markets.

He served as the Assistant Secretary of the Navy (Financial Management and Comptroller) from 2004 to 2006. Prior to his confirmation by the Senate, Mr. Greco was a White House Fellow from 2002 to 2003 and also served as the acting Director of Private Sector Development for Iraq at the Coalition Provisional Authority Representative's Office.

Prior to government service, Mr. Greco was a managing director of the corporate finance advisory firm of Stern Stewart & Co., where he specialized in EVA(R)-based corporate governance systems, performance measurement and management, incentive compensation, corporate valuation, and financial market research. Before joining Stern Stewart in 1997 he was an Associate at The Scowcroft Group, an investment advisory firm. The author of many articles on finance, corporate governance, and foreign policy, Mr. Greco holds an M.B.A. in finance from The University of Chicago Graduate School of Business, an M.A. from The Johns Hopkins University Paul H. Nitze School of Advanced International Studies, and a B.S. in Chemistry Summa Cum Laude, In Cursu Honorum from Fordham University.

Mr. Churchill, 74, a practicing attorney in New York City, had been a director of Mediware since 1992. Mr. Churchill received a B.A. degree from Harvard College and an L.L.B. from Harvard Law School.

"Jon has been a tremendous asset to Mediware during his term as a director," said the Company's chairman, Lawrence Auriana. "His legal and business acumen have repeatedly been of tremendous value to the organization."

About Mediware

Mediware delivers powerful software solutions that encapsulate patient care instructions, reinforce patient safety practices and improve efficiencies to lower costs. For blood medication management, Mediware offers specialized solutions proven to improve operational effectiveness and clinical outcomes. Mediware customers include prestigious hospitals, clinics, correctional

institutions, blood centers and other public and private health care institutions throughout the world.

Contact: Mark Williams Thomas Redington

Chief Financial Officer, Mediware 203 222-7399

913 307-1000 212 926-1733

http://www.mediware.com http://www.redingtoninc.com


'/>"/>
SOURCE Mediware Information Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Gere Joins Indian Stars For Fight Against AIDS
2. Rise in Esophageal Cancer is emphasized by Richards’ deat
3. Richard Gere Urges Truck Drivers to Have Safe Sex
4. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
5. Rat joins list of cloned animals
6. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
7. Anoushka Joins Hands With WFP to Feed the Poor
8. India Joins Hands With Global Body for Vaccine Research
9. Another Statewide Organization Joins the Fight Against Assisted Suicide
10. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... During the last ... provide free screening colonoscopies to eligible individuals in the local community. , Colon ... but regular screenings can detect colon cancer while it is small, confined and easier ...
(Date:3/29/2017)... , ... March 29, 2017 , ... Full Contact K9, ... of Pet Protect Law that assists dog owners in creating legally-enforceable pet ... owners in taking the natural next step to protect their new companion. Says Evan ...
(Date:3/29/2017)... Petersburg, FL (PRWEB) , ... March 30, 2017 , ... ... called the "Spice of Life" or "Wonder Spice", it has been used for thousands ... use in the East," says Heshelow, author of " Turmeric: How to Use it ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wall Centre Dental ... new patients from Burnaby, BC. Patients in need of experienced orthodontics, laser dentistry, ... see the esteemed team at Wall Centre Dental. Drs. Parviz Roshan, Siamak Tehrani, ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... as it continues developing an ANSI-approved, consensus-based American National Standard for Good ... to publish the first ANSI-approved GMP standard for dietary supplements this spring, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  The Global ... Japanese public-private partnership formed to battle infectious diseases ... totaling US$23 million* that could help deliver a ... of debilitating conditions. This latest ... Phase 3 clinical trial testing a pediatric formulation ...
(Date:3/29/2017)... TREE, Colo. , March 29, 2017  Zynex (OTCQB: ... manufacture and sale of non-invasive medical devices for pain ... today that it will host the Company,s 2016 full-year ... a.m. Eastern Time.) The Company expects to ... 31, 2017. ...
(Date:3/29/2017)... 29, 2017  Glenmark Pharmaceuticals, a global pharmaceutical ... an investigational fixed-dose combination of mometasone furoate (25 ... as a nasal spray being studied for the ... from a recently completed Phase 3 trial assessing ... therapy versus mometasone, olopatadine or placebo. ...
Breaking Medicine Technology: